Document is current

Article History

Received: 11 January 2025

Accepted: 21 March 2025

First Online: 11 April 2025

Declarations

: Ethical Considerations All ethical considerations for observational studies, including the ethical use of documents and scientific evidence in executing this thesis, were adhered to. No disclosures that could jeopardize the intellectual property rights of the participants were present in this study. All patients were fully informed about the study by reviewing and approving the informed consent form, and the patients incurred no additional costs. All aspects of the Helsinki Declaration regarding the findings' conduct, collection, interpretation, and publication were considered. Additionally, the proposal for this study was approved by the Regional Ethics Committee with the code IR.TBZMED.REC.1402.060 registered with the Clinical Trials Center of Iran under the code IRCT20120922010901N10.

: The authors declare no conflict of interest.

: The study protocol was registered and confirmed in the Iranian Registry of Clinical Trials under the number (IRCT20120922010901N10). Registration date: 1402/02/18 , 2023-05-08 URL to registration on the trial registry website: Date of enrollment of the first subject: 1402/02/18, 2023-05-08